Milestone Pharmaceuticals Inc (NASDAQ: MIST) Is Getting Increasingly Hard To Ignore
Currently, there are 53.46M common shares owned by the public and among those 52.90M shares have been available to trade. The company’s stock has a 5-day price change of -19.59% and 115.68% over the past three months. MIST shares are trading 7.59% year to date (YTD), with the 12-month market performance down to -33.90% lower. […]